BioSpace News Archive

BioMidwest

CardioMech Raises $13m in Heavily Oversubscribed Round for Its Transcatheter Mitral Chordal Repair Technology

Norway-based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology in Fridley, MN, announced it has closed on $13M in fresh capital.

January 2, 2024
·
2 min read
NanoPhoria Bioscience Publishes Groundbreaking Study in Major Cardiology Journal

NanoPhoria srl, a pre-clinical stage biotech company, is pleased to announce the publication of a groundbreaking study in the field of cardiology, conducted using a clinically relevant pig model of heart failure.

January 2, 2024
·
4 min read
Mabwell to attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase

Mabwell, an innovative biopharmaceutical company with entire industry chain, announced that Dr. Hai Wu, R&D VP of Mabwell, will attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase in San Francisco, United States.

January 2, 2024
·
5 min read
Drug Development

Inventprise Completes Vaccination of Participants in a Phase 2 Dose Ranging Study of its 25 Valent Pneumococcal Vaccine Candidate

Biotechnology company Inventprise Inc.n announced the completion of vaccination in their Phase 2 dose ranging study of its 25-valent pneumococcal conjugate vaccine in young adults.

January 2, 2024
·
4 min read
Genetown

Sage Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024

Sage Therapeutics, Inc. announced today that the Company will present at the 42 nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 4:30 p.m. PT in San Francisco, CA.

January 2, 2024
·
1 min read
Drug Development

South Rampart Pharma Successfully Completes Phase 1 Study and Expands Phase 2 Plans to Include Neuropathic and Acute Pain Trials

South Rampart Pharma, Inc. announced today that it has successfully completed a Phase 1 trial (NCT05484414).

January 2, 2024
·
6 min read
Genetown

Syndax Highlights Recent Updates and Anticipated 2024 Milestones

Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today highlighted recent updates and anticipated 2024 milestones.

January 2, 2024
·
9 min read
Genetown

Deciphera Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Deciphera Pharmaceuticals, Inc. today announced that Steve Hoerter, President and Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 4:30 PM PT / 7:30 PM ET.

January 2, 2024
·
1 min read
Biotech Bay

Apogee Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Apogee Therapeutics, Inc. today announced that Michael Henderson, M.D., Chief Executive Officer of Apogee, will present at the 42nd Annual J.P. Morgan Conference on Tuesday, January 9, 2024 at 7:30 a.m. P.T. / 10:30 a.m. E.T.

January 2, 2024
·
1 min read
Theratechnologies Submits sBLA for Trogarzo® Intramuscular (IM) Method of Administration to FDA

Theratechnologies Inc today announced that the Company has filed a supplemental Biologics License Application (sBLA) for an intramuscular (IM) method of administration for the maintenance dose of Trogarzo® (ibalizumab-uiyk) to the United States Food and Drug Administration (FDA) for review.

January 2, 2024
·
7 min read